Call Options Transactions Made in Q3 2023 in Blueprint Medicines Corp (BPMC)
This table provides information about the institutional ownership of Blueprint Medicines Corp (BPMC) during Q3 2023. The information is specifically focused on institutions that hold call options of Blueprint Medicines Corp.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2023
Q3 2023
|
Ubs Oconnor LLC
Chicago, IL |
BUY
|
CALL |
25KNew |
$1.17M - $1.65M
|
25K
$2.19M
|
|
Nov 14, 2023
Q3 2023
|
Caption Management, LLC
Oklahoma City, OK |
BUY
|
CALL |
25KNew |
$1.17M - $1.65M
|
25K
$2.19M
|
|
Nov 13, 2023
Q3 2023
|
Peak6 Investments LLC
Chicago, IL |
BUY
|
CALL |
11.1K+ 42.05% |
$521K - $733K
|
37.5K
$3.28M
|
|
Nov 14, 2023
Q3 2023
|
Jefferies Financial Group Inc.
New York, NY |
BUY
|
CALL |
10.5KNew |
$492K - $693K
|
10.5K
$918K
|
|
Nov 14, 2023
Q3 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
7.3K+ 112.31% |
$342K - $482K
|
13.8K
$1.21M
|
|
Nov 14, 2023
Q3 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
CALL |
-21.9K- 32.88% |
$1.03M - $1.45M
|
44.7K
$3.91M
|